Literature DB >> 62720

Serum alpha-fetoprotein as a marker for the effect of post-operative radiation therapy and/or chemotherapy in eight cases of ovarian endodermal sinus tumour.

A Sell, H Sogaard, B Norgaard-Pedersen.   

Abstract

The clinical pathological findings of eight cases of ovarian endodermal sinus tumour (yolk sac tumour) are presented. Histological exmination in all eight cases showed a typical endodermal sinus tumour pattern, and in six of the patients other tumour elements such as dysgerminoma, choriocarcinoma, malignant teratoma, endometriosis, and a dermoid cyst were also found. Six patients had increased serum alpha-fetoprotein concentration in the post-operative period, and two patients had a normal concentration 27 and 35 days after operation, respectively. In all cases except one, a close correlation between serum alpha-fetoprotein and progression or regression of tumour was found. Serum alphafetoprotein was thus found to be a reliable parameter in post-operative radiation and/or chemotherapy (VAMBLE). In one patient who died 10 months after operation with widespread endodermal sinus tumour growth, only a small terminal increase in serum alpha-fetoprotein concentration was found. Four of the eight women are still alive with normal alpha-fetoprotein concentration, and without clinical evidence of tumour disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 62720     DOI: 10.1002/ijc.2910180505

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Prognostic value of serum α-fetoprotein in ovarian yolk sac tumors: A systematic review and meta-analysis.

Authors:  Yang-Long Guo; Ying-Li Zhang; Jian-Qing Zhu
Journal:  Mol Clin Oncol       Date:  2014-09-18

2.  Pregnancy and Delivery After Ovarian Yolk Sac Tumor: A Case Report.

Authors:  Mo'ath M Alrjoub; Amer Sindiani; Ola Alshriedeh; Zouhair Amarin
Journal:  Am J Case Rep       Date:  2021-08-19

3.  Practical applications of a monoclonal antibody (NDOG2) against placental alkaline phosphatase in ovarian cancer.

Authors:  J O Davies; E R Davies; K Howe; P Jackson; E Pitcher; B Randle; C Sadowski; G M Stirrat; C A Sunderland
Journal:  J R Soc Med       Date:  1985-11       Impact factor: 5.344

4.  The detection and measurement of oncodevelopmental proteins in gynecological malignant disease.

Authors:  C Cerni; G Tatra
Journal:  Arch Gynecol       Date:  1982

5.  Products of gynaecological neoplasms: clinical and pathological applications.

Authors:  A M Neville
Journal:  Arch Gynecol       Date:  1980

6.  Successful treatment of advanced stage yolk sac tumour of extragonadal origin: a case report and review of literature.

Authors:  Vilius Rudaitis; Ugnius Mickys; Justina Katinaitė; Justyna Dulko
Journal:  Acta Med Litu       Date:  2016

7.  Role of Radiotherapy in Recurrent Intra-Abdominal Yolk Sac Tumor.

Authors:  Marhendra Satria Utama; Andi Kurniadi; A A Citra Yunda Prahastiwi; Antony A Adibrata
Journal:  Case Rep Oncol       Date:  2021-06-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.